OBJECTIVES: To develop mortality risk prediction models for older adults with chronic kidney disease (CKD) that include comorbidities and measures of health status and use not associated with particular comorbid conditions (nondisease-specific measures). DESIGN: Retrospective cohort study. SETTING: Kaiser Permanente Northwest (KPNW) Health Maintenance Organization. PARTICIPANTS: Individuals with severe CKD (estimated glomerular filtration rate<30 mL/min per 1.73 m2; N=4,054; n=1,915 aged 65-79, n=2,139 aged ≥80) who received care at KPNW between 2000 and 2008. MEASUREMENTS: Cox proportional hazards analysis was used to examine the association between selected participant characteristics and all-cause mortality and to generate age group-specific risk prediction models. Predicted and observed risks were evaluated according to quintile. Predictors from the Cox models were translated into a points-based system. Internal validation was used to provide best estimates of how these models might perform in an external population. RESULTS: The risk prediction models used 16 characteristics to identify participants with the highest risk of mortality at 2 years for adults aged 65 to 79 and 80 and older. Predicted and observed risks agreed within 5% for each quintile; a 4 to 5 times difference in 2-year predicted mortality risk was observed between the highest and lowest quintiles. The c-statistics for each model (0.68-0.69) indicated effective discrimination without evidence of significant overfit (slope shrinkage 0.06-0.09). Models for each age group performed similarly for mortality prediction at 6 months and 2 years in terms of discrimination and calibration. CONCLUSION: When validated, these risk prediction models may be helpful in supporting discussions about prognosis and treatment decisions sensitive to prognosis in older adults with CKD in real-world clinical settings.
OBJECTIVES: To develop mortality risk prediction models for older adults with chronic kidney disease (CKD) that include comorbidities and measures of health status and use not associated with particular comorbid conditions (nondisease-specific measures). DESIGN: Retrospective cohort study. SETTING: Kaiser Permanente Northwest (KPNW) Health Maintenance Organization. PARTICIPANTS: Individuals with severe CKD (estimated glomerular filtration rate<30 mL/min per 1.73 m2; N=4,054; n=1,915 aged 65-79, n=2,139 aged ≥80) who received care at KPNW between 2000 and 2008. MEASUREMENTS: Cox proportional hazards analysis was used to examine the association between selected participant characteristics and all-cause mortality and to generate age group-specific risk prediction models. Predicted and observed risks were evaluated according to quintile. Predictors from the Cox models were translated into a points-based system. Internal validation was used to provide best estimates of how these models might perform in an external population. RESULTS: The risk prediction models used 16 characteristics to identify participants with the highest risk of mortality at 2 years for adults aged 65 to 79 and 80 and older. Predicted and observed risks agreed within 5% for each quintile; a 4 to 5 times difference in 2-year predicted mortality risk was observed between the highest and lowest quintiles. The c-statistics for each model (0.68-0.69) indicated effective discrimination without evidence of significant overfit (slope shrinkage 0.06-0.09). Models for each age group performed similarly for mortality prediction at 6 months and 2 years in terms of discrimination and calibration. CONCLUSION: When validated, these risk prediction models may be helpful in supporting discussions about prognosis and treatment decisions sensitive to prognosis in older adults with CKD in real-world clinical settings.
Authors: Ann M O'Hare; Daniel Bertenthal; Kenneth E Covinsky; C Seth Landefeld; Saunak Sen; Kala Mehta; Michael A Steinman; Ann Borzecki; Louise C Walter Journal: J Am Soc Nephrol Date: 2006-02-01 Impact factor: 10.121
Authors: Ann M O'Hare; Andy I Choi; Daniel Bertenthal; Peter Bacchetti; Amit X Garg; James S Kaufman; Louise C Walter; Kala M Mehta; Michael A Steinman; Michael Allon; William M McClellan; C Seth Landefeld Journal: J Am Soc Nephrol Date: 2007-09-12 Impact factor: 10.121
Authors: Elise C Carey; Kenneth E Covinsky; Li-Yung Lui; Catherine Eng; Laura P Sands; Louise C Walter Journal: J Am Geriatr Soc Date: 2007-11-20 Impact factor: 5.562
Authors: Giampiero Mazzaglia; Lorenzo Roti; Giacomo Corsini; Angela Colombini; Gavino Maciocco; Niccolò Marchionni; Eva Buiatti; Luigi Ferrucci; Mauro Di Bari Journal: J Am Geriatr Soc Date: 2007-10-18 Impact factor: 5.562
Authors: Sei J Lee; Alan S Go; Karla Lindquist; Daniel Bertenthal; Kenneth E Covinsky Journal: Am J Public Health Date: 2008-05-29 Impact factor: 9.308
Authors: William F Keane; Zhongxin Zhang; Paulette A Lyle; Mark E Cooper; Dick de Zeeuw; Jean-Pierre Grunfeld; James P Lash; Janet B McGill; William E Mitch; Giuseppe Remuzzi; Shahnaz Shahinfar; Steven M Snapinn; Robert Toto; Barry M Brenner Journal: Clin J Am Soc Nephrol Date: 2006-05-17 Impact factor: 8.237
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Noel Engels; Gretchen N de Graav; Paul van der Nat; Marinus van den Dorpel; Anne M Stiggelbout; Willem Jan Bos Journal: BMJ Open Date: 2022-09-21 Impact factor: 3.006
Authors: Brian Forzley; Helen H L Chiu; Ognjenka Djurdjev; Rachel C Carson; Gaylene Hargrove; Dan Martinusen; Mohamud Karim Journal: Can J Kidney Health Dis Date: 2017-08-18
Authors: Jason Roy; Haochang Shou; Dawei Xie; Jesse Y Hsu; Wei Yang; Amanda H Anderson; J Richard Landis; Christopher Jepson; Jiang He; Kathleen D Liu; Chi-Yuan Hsu; Harold I Feldman Journal: Clin J Am Soc Nephrol Date: 2016-09-22 Impact factor: 10.614
Authors: Morgan E Grams; Yingying Sang; Shoshana H Ballew; Juan Jesus Carrero; Ognjenka Djurdjev; Hiddo J L Heerspink; Kevin Ho; Sadayoshi Ito; Angharad Marks; David Naimark; Danielle M Nash; Sankar D Navaneethan; Mark Sarnak; Benedicte Stengel; Frank L J Visseren; Angela Yee-Moon Wang; Anna Köttgen; Andrew S Levey; Mark Woodward; Kai-Uwe Eckardt; Brenda Hemmelgarn; Josef Coresh Journal: Kidney Int Date: 2018-03-29 Impact factor: 18.998